D-0256-2025 Class II Ongoing
FDA drug recall D-0256-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on Feb 13, 2025 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 1,893 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 12, 2025
- Initiation Date
- Feb 13, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,893 vials
Product description
Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1839-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
USA Nationwide
Code information
Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26; b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0256-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026